Article citationsMore>>

Howard Jr., J.F., Bril, V., Vu, T., et al. (2022) Safety and Efficacy of Ravulizumab in Adults with Generalized Myasthenia Gravis: The Champion-Mg Trial. The Lancet Neurology, 21, 589-600.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top